BENKOWITZ MICHAEL sold UTHR

November 17, 2025 · Form 4 insider transaction

BENKOWITZ MICHAEL sold 14,625 shares of United Therapeutics Corporation at $470.43 per share, a transaction worth $6.88M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
14,625
Price
$470.43
Total value
$6.88M
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 17, 2025
Filing dateNovember 18, 2025
Shares owned after0
OwnershipIndirect
10b5-1 planYes
AmendedNo

Footnotes

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 7, 2024.; Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.

View the original Form 4 on SEC EDGAR
BENKOWITZ MICHAEL sold UTHR: November 17, 2025 | Insider Trading Screener